Healthcare consulting and technology company D2 Solutions announced on Thursday that it has acquired ProModRx, a cloud-based technology platform designed to help speed patient access to prescription medications.
This acquisition aims to expand D2's services to better assist pharmaceutical and medical device manufacturers, traditional hubs and pharmacies across the full scope of the patient journey. That support includes therapy initiation, prescription capture, electronic benefits verification, prior authorisation support, dispensing coordination and ongoing patient engagement.
The deal is also expected to strengthen D2's support for pharmaceutical and medical device manufacturers that depend on reimbursement support, enrolment and product access coordination and extends its offering across retail, hospital, mail-order and specialty pharmacy channels.
As part of the acquisition, ProModRx employees will continue to support the business and Jerry Smith, ProModRx's general manager, will be joining D2 Solutions' executive team.
GSK strengthens pulmonary hypertension pipeline with USD950m acquisition of 35Pharma
Asgard Therapeutics appoints chief medical officer
Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting
hVIVO signs influenza human challenge trial agreement with Traws Pharma
Hoth Therapeutics reports positive HT-VA CRADA data
Kelun-Biotech reports Phase II study results for sac-TMT at 2026 SGO
Genmab reports positive safety data for Rina-S combination in ovarian cancer
GSK reports strong early-stage data for B7-H4 ADC in gynaecological cancers
FDA grants priority review to ifinatamab deruxtecan in small cell lung cancer
Almirall expands supercomputing and AI collaboration with Barcelona Supercomputing Center